{"DataElement":{"publicId":"3433492","version":"3","preferredName":"Correlative Study Specimen Collection Ind-3b","preferredDefinition":"The yes/no/not applicable indicator related to the samples (blood, urine, tissue, etc.) collection in a laboratory, pharmacokinetic or other correlative study embedded within the primary protocol.","longName":"BdSpcObtCrrBioSdyTP","context":"COG","contextVersion":"1","DataElementConcept":{"publicId":"2422060","version":"1.1","preferredName":"Correlative Study Specimen Collection","preferredDefinition":"A type of study that tests for a relationship between a condition and a potential causal factor of the condition._A part of a thing, or of several things, taken to demonstrate or to determine the character of the whole, e.g. a substance, or portion of material obtained for use in testing, examination, or study; particularly, a preparation of tissue or bodily fluid taken for examination or diagnosis.:The act of gathering things together; having been brought together in one place.","longName":"CORR_ST_SPEC_COLL","context":"CTEP","contextVersion":"2.31","ObjectClass":{"publicId":"2422056","version":"1","preferredName":"Correlative Study Specimen","preferredDefinition":"Studies designed to translate basic science findings into clinically useful tools.  Includes marker research.:Specimen; a bit of tissue or blood or urine that is taken or used for research purposes.","longName":"C16100:C19157","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Correlative Study","conceptCode":"C16100","definition":"A type of study that tests for a relationship between a condition and a potential causal factor of the condition.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Specimen","conceptCode":"C19157","definition":"A part of a thing, or of several things, taken to demonstrate or to determine the character of the whole, e.g. a substance, or portion of material obtained for use in testing, examination, or study; particularly, a preparation of tissue or bodily fluid taken for examination or diagnosis.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"037D65D9-946B-6192-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-10-19","endDate":null,"createdBy":"ALAIS","dateCreated":"2005-10-19","modifiedBy":"ONEDATA","dateModified":"2005-10-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2413010","version":"1","preferredName":"Collection","preferredDefinition":"The act of gathering something together.","longName":"C25453","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Collection","conceptCode":"C25453","definition":"The act of gathering things together; having been brought together in one place.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"01EC6FE0-A477-4EB4-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-09-30","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-09-30","modifiedBy":"ONEDATA","dateModified":"2005-09-30","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008547","version":"1","preferredName":"Specimen Characteristics","preferredDefinition":"attributes of a patient's laboratory sample, including the source, condition, and fixative.","longName":"SPEC_CHAR","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22908C4-638F-4A74-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F784ECC3-3D33-7F5A-E053-731AD00AAC5F","latestVersionIndicator":"Yes","beginDate":"2005-10-06","endDate":null,"createdBy":"ZHWENDY","dateCreated":"2023-03-22","modifiedBy":"KUMMEROA","dateModified":"2023-06-05","changeDescription":null,"administrativeNotes":"2023.6.5 Released. ak 3/23/2023:versioned to replace the retired concept. wz","unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"3506036","version":"1","preferredName":"Yes No Not Applicable Indicator","preferredDefinition":"The preferred Value Domain to indicate a question with permissible values of yes/no/not applicable.","longName":"YES_NO_NA_IND","context":"NCI Standards","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":"2","maxLength":"14","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Not Applicable","valueDescription":"Not Applicable","ValueMeaning":{"publicId":"3261243","version":"1","preferredName":"Not Applicable","longName":"3261243","preferredDefinition":"Determination of a value is not relevant in the current context.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Not Applicable","conceptCode":"C48660","definition":"Determination of a value is not relevant in the current context.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"AA2BBD66-6581-A6F2-E040-BB89AD4311D3","latestVersionIndicator":"Yes","beginDate":"2011-08-10","endDate":null,"createdBy":"ALAIS","dateCreated":"2011-08-10","modifiedBy":"RAGUNATHANU","dateModified":"2024-02-05","changeDescription":"12/15/15 added N/A as alternate VM-tt.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C37A1BEB-759A-B6C9-E040-BB89AD434179","beginDate":"2012-06-27","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2012-06-27","modifiedBy":"ONEDATA","dateModified":"2012-06-27","deletedIndicator":"No"},{"value":"Yes","valueDescription":"Yes","ValueMeaning":{"publicId":"3197153","version":"1","preferredName":"Yes","longName":"3197153v1.00","preferredDefinition":"The affirmative response to a question.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Yes","conceptCode":"C49488","definition":"The affirmative response to a question.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9D865DE5-558A-1AC9-E040-BB89AD436B4F","latestVersionIndicator":"Yes","beginDate":"2011-03-02","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2011-03-02","modifiedBy":"SOKKERL","dateModified":"2023-12-05","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C37A1BEB-75A4-B6C9-E040-BB89AD434179","beginDate":"2012-06-27","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2012-06-27","modifiedBy":"ONEDATA","dateModified":"2012-06-27","deletedIndicator":"No"},{"value":"No","valueDescription":"No","ValueMeaning":{"publicId":"3197154","version":"1","preferredName":"No","longName":"3197154","preferredDefinition":"The non-affirmative response to a question.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"No","conceptCode":"C49487","definition":"The non-affirmative response to a question.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9D865DE5-55AD-1AC9-E040-BB89AD436B4F","latestVersionIndicator":"Yes","beginDate":"2011-03-02","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2011-03-02","modifiedBy":"SOKKERL","dateModified":"2023-12-05","changeDescription":null,"administrativeNotes":"2022.12.28 Alt VM added per ticket request CADSR0001837. aj","unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C37A1BEB-7590-B6C9-E040-BB89AD434179","beginDate":"2012-06-27","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2012-06-27","modifiedBy":"ONEDATA","dateModified":"2012-06-27","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"3502157","version":"1","preferredName":"Yes No Indicator Value Domains","preferredDefinition":"Conceptual domain that includes value meanings to be used for Indicator Value Meanings such as Yes, No, Unknown, No Applicable","longName":"YES_NO_IND_VD","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"C377DE0C-8C3E-DCA8-E040-BB89AD431B6D","latestVersionIndicator":"Yes","beginDate":"2012-06-27","endDate":null,"createdBy":"CURTIST","dateCreated":"2012-06-27","modifiedBy":"CURTIST","dateModified":"2012-06-27","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2694966","version":"1","preferredName":"Ind-3b","preferredDefinition":"A response or indicator that can have a value of yes, no, or not applicable.","longName":"C49797","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Yes, No, or Not Applicable Response","conceptCode":"C49797","definition":"A response or indicator that can have a value of yes, no, or not applicable.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RETIRED ARCHIVED","registrationStatus":"Retired","id":"3EBCA780-282F-4411-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-11-12","endDate":"2016-04-27","createdBy":"CURTIST","dateCreated":"2007-11-12","modifiedBy":"TAYLORT","dateModified":"2020-10-02","changeDescription":"10.2.20 TL changed WFS from RETIRED PHASED OUT to RETIRED ARCHIVED. Retired DBW 04-27-2016 per Tina Taylor approved by Dianne Reves","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Standard","id":"C37A1BEB-757C-B6C9-E040-BB89AD434179","latestVersionIndicator":"Yes","beginDate":"2012-06-27","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2012-06-27","modifiedBy":"ZHANGWE","dateModified":"2019-01-24","changeDescription":"3/12/17 jk added Standard reg status; ownership transfered from CTEP to NCI Standards with concurrence of CTEP/Brian Campbell. 8/3/2015 Corrections made to VD in order to restore to original format: removed C49486 as rep term and replaced with C49797; restored long name and definition per Dianne Reeves/tt.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2961451","version":"1","longName":"Children's Oncology Group (COG)","context":"COG","ClassificationSchemeItems":[{"publicId":"3303197","version":"1","longName":"Phase 1/Pilot Consortium","context":"COG"},{"publicId":"2961452","version":"1","longName":"Statistics and Data Center","context":"COG"}]},{"publicId":"3886752","version":"1","longName":"For Review","context":"DCI","ClassificationSchemeItems":[{"publicId":"3891931","version":"1","longName":"For Review","context":"DCI"}]},{"publicId":"4254096","version":"1","longName":"Protocol Phase","context":"PBTC","ClassificationSchemeItems":[{"publicId":"10000103","version":"1","longName":"Phase I","context":"PBTC"},{"publicId":"4254119","version":"1","longName":"PBTC-042","context":"PBTC"}]}],"AlternateNames":[{"name":"SpcClcBioSdy","type":"COG GDE Short Name","context":"COG"},{"name":"PBTC","type":"USED_BY","context":"PBTC"},{"name":"BdSpcObtCrrBioSdyTP","type":"USED_BY","context":"Alliance"},{"name":"DCI","type":"USED_BY","context":"DCI"},{"name":"COG","type":"USED_BY","context":"COG"},{"name":"BdSpcObtCrrBioSdyTP","type":"USED_BY","context":"CCTG"},{"name":"CORR_STDY_SPEC_COLL_IND","type":"OID, CCTG","context":"CCTG"},{"name":"CCTG","type":"USED_BY","context":"CCTG"}],"ReferenceDocuments":[{"name":"CRF Text2","type":"Alternate Question Text","description":"Were specimens collected for the sub-studies?","url":null,"context":"CTEP"},{"name":"COG CRF Text 2","type":"Alternate Question Text","description":"Were the optional specimens collected for the Ancillary study?","url":null,"context":"CTEP"},{"name":"PQT","type":"Preferred Question Text","description":"Were specimens collected for correlative biology study?","url":null,"context":"COG"},{"name":"CRF Text1","type":"Alternate Question Text","description":"Was blood specimen collected for the Correlative Science sub-study?","url":null,"context":"CTEP"},{"name":"COG CRF Text 3","type":"Alternate Question Text","description":"Were biology specimens obtained?","url":null,"context":"COG"},{"name":"COG CRF Text 1","type":"Alternate Question Text","description":"Were specimens collected for MDD/MRD studies?","url":null,"context":"CTEP"},{"name":"COG CRF Text 4","type":"Alternate Question Text","description":"Were specimens collected for correlative biology study?","url":null,"context":"COG"},{"name":"PBTC_Text2","type":"Alternate Question Text","description":"PG Sample collected?","url":null,"context":"PBTC"},{"name":"PBTC_Text3","type":"Alternate Question Text","description":"Was PK sample obtained after Dexamethasone was discontinued?","url":null,"context":"PBTC"},{"name":"COG CRF Text 6","type":"Alternate Question Text","description":"Is snap-frozen tumor tissue available for submission if needed for Genomic Profile Analysis?","url":null,"context":"COG"},{"name":"COG CRF Text 5","type":"Alternate Question Text","description":"Was sample collected for Eribulin Pharmacokinetic Study?","url":null,"context":"COG"},{"name":"PBTC_Text1","type":"Alternate Question Text","description":"PK Plasma Samples collected?","url":null,"context":"PBTC"},{"name":"PBTC_Text4","type":"Alternate Question Text","description":"Were specimens collected for Genomics Study?","url":null,"context":"PBTC"},{"name":"PBTC_Text5","type":"Alternate Question Text","description":"CSF PK Samples collected?","url":null,"context":"PBTC"},{"name":"PBTC_Text7","type":"Alternate Question Text","description":"Blood-Cytokines sample collected?","url":null,"context":"PBTC"},{"name":"COG_CRF_Text_7","type":"Alternate Question Text","description":"Were blood specimens obtained for correlative biology study","url":null,"context":"COG"},{"name":"PBTC_Text6","type":"Alternate Question Text","description":"Were PBMC Blood specimens collected?","url":null,"context":"PBTC"},{"name":"PBTC_Text9","type":"Alternate Question Text","description":"Was blood specimen collected for Anti-tumor monitoring studies?","url":null,"context":"PBTC"},{"name":"PBTC_Text8","type":"Alternate Question Text","description":"Blood-NK, Granzyme B, T-cell sample collected?","url":null,"context":"PBTC"},{"name":"COG CRF Text 8","type":"Alternate Question Text","description":"Were specimens collected in Induction for Optional Coagulation study?","url":null,"context":"COG"},{"name":"COG_CRF_TEXT_14","type":"Alternate Question Text","description":"Was sample collected at Day 15 of Cycle 6 for Denosumab Pharmacokinetic Study?","url":null,"context":"COG"},{"name":"COG CRF Text 15","type":"Alternate Question Text","description":"Was sample collected for ch 14.18 (Dinutuximab) Pharmacokinetic Study?","url":null,"context":"COG"},{"name":"COG CRF Text 16","type":"Alternate Question Text","description":"Was sample collected for ch 14.18 (Dinutuximab) HACA Study?","url":null,"context":"COG"},{"name":"COG CRF Text 17","type":"Alternate Question Text","description":"Was tissue collected for GD2 expression?","url":null,"context":"COG"},{"name":"COG CRF Text 18","type":"Alternate Question Text","description":"Was blood collected for the biology studies?","url":null,"context":"COG"},{"name":"PBTC_Text14","type":"Alternate Question Text","description":"Was FFPE tissue provided for Immunologic monitoring studies?","url":null,"context":"PBTC"},{"name":"COG CRF Text 10","type":"Alternate Question Text","description":"Were Pharmacokinetic samples submitted during this reporting period?","url":null,"context":"COG"},{"name":"COG CRF Text 9","type":"Alternate Question Text","description":"Was tumor available for submission?","url":null,"context":"COG"},{"name":"COG_CRF_TEXT_12","type":"Alternate Question Text","description":"Was serum specimen collected for Denosumab Pharmacodynamics study?","url":null,"context":"COG"},{"name":"COG_CRF_TEXT_13","type":"Alternate Question Text","description":"Was sample collected for Denosumab Pharmacokinetic Study?","url":null,"context":"COG"},{"name":"PBTC-Text11","type":"Alternate Question Text","description":"Was FFPE tissue provided for IHC studies?","url":null,"context":"PBTC"},{"name":"PBTC-Text12","type":"Alternate Question Text","description":"Was FFPE tissue provided for Gene expression studies?","url":null,"context":"PBTC"},{"name":"PBTC_Text10","type":"Alternate Question Text","description":"Was FFPE  tissue provided for Anti-tumor monitoring studies?","url":null,"context":"PBTC"},{"name":"PBTC_Text13","type":"Alternate Question Text","description":"Was frozen tissue provided for Anti-tumor monitoring studies?","url":null,"context":"PBTC"},{"name":"COG_ CRF_TEXT_ 11","type":"Alternate Question Text","description":"Was urine specimen collected for Denosumab Pharmacodynamics study?","url":null,"context":"COG"},{"name":"PBTC_Text15","type":"Alternate Question Text","description":"Were samples provided for the repository?","url":null,"context":"PBTC"},{"name":"COG CRF Text 19","type":"Alternate Question Text","description":"Was samples collected for CDX-011 Pharmacokinetic study?","url":null,"context":"COG"},{"name":"CRF Text3","type":"Alternate Question Text","description":"Were blood specimens submitted this reporting period?","url":null,"context":"Alliance"},{"name":"PBTC_Text16","type":"Alternate Question Text","description":"Were FFPE tumor samples provided for the central pathology review?","url":null,"context":"PBTC"},{"name":"CRF Text5","type":"Alternate Question Text","description":"Were specimens submitted this reporting period?","url":null,"context":"Alliance"},{"name":"CRF Text4","type":"Alternate Question Text","description":"Were tissue specimens submitted this reporting period?","url":null,"context":"Alliance"},{"name":"PBTC_Text19","type":"Alternate Question Text","description":"Was a fresh tissue sample provided for Immunology?","url":null,"context":"PBTC"},{"name":"COG CRF Text 20","type":"Alternate Question Text","description":"Were Pharmacokinetic and Pharmacodynamics samples submitted during this reporting period?","url":null,"context":"COG"},{"name":"PBTC_Text24","type":"Alternate Question Text","description":"Were blood samples collected for pharmacokinetics (PK) study?","url":null,"context":"PBTC"},{"name":"PBTC_Text26","type":"Alternate Question Text","description":"Were blood samples collected for circulating cytokines and T cell phenotype studies?","url":null,"context":"PBTC"},{"name":"PBTC_Text28","type":"Alternate Question Text","description":"Was Blood specimen collected for tumor mutation burden assessment (exome sequencing)?","url":null,"context":"PBTC"},{"name":"PBTC_Text29","type":"Alternate Question Text","description":"Phase 1 PK samples collected?","url":null,"context":"PBTC"},{"name":"PBTC_Text17","type":"Alternate Question Text","description":"Was blood provided for immunophenotyping?","url":null,"context":"PBTC"},{"name":"PBTC_Text18","type":"Alternate Question Text","description":"Was blood provided for Repertoire and Methylation Analysis?","url":null,"context":"PBTC"},{"name":"PBTC_Text20","type":"Alternate Question Text","description":"Were samples provided for Genomics research?","url":null,"context":"PBTC"},{"name":"PBTC_Text27","type":"Alternate Question Text","description":"Was pre-trial frozen or FFPE tumor tissue provided for tumor mutation burden assessment (exome sequencing)?","url":null,"context":"PBTC"},{"name":"PBTC_Text23","type":"Alternate Question Text","description":"Pharmacodynamics tissue samples collected?","url":null,"context":"PBTC"},{"name":"PBTC_Text25","type":"Alternate Question Text","description":"Were blood samples collected for Anti-Drug Antibody (ADA) assay?","url":null,"context":"PBTC"},{"name":"PBTC_Text22","type":"Alternate Question Text","description":"Course 1 PK  samples collected?","url":null,"context":"PBTC"},{"name":"PBTC_Text21","type":"Alternate Question Text","description":"Surgical PK samples collected?","url":null,"context":"PBTC"},{"name":"CRF Text6","type":"Alternate Question Text","description":"Were blood specimens submitted?","url":null,"context":"Alliance"},{"name":"CRF Text7","type":"Alternate Question Text","description":"Were tissue specimens submitted?","url":null,"context":"Alliance"},{"name":"CRF Text8","type":"Alternate Question Text","description":"Were stool specimens submitted?","url":null,"context":"Alliance"},{"name":"CE7","type":"Alternate Question Text","description":"Have the baseline correlative study samples been obtained for this patient, and the required samples (cfDNA) sent immediately to the relevant pathology lab?","url":null,"context":"CCTG"},{"name":"COG CRF Text 21","type":"Alternate Question Text","description":"Was sample collected for ctDNA correlative study?","url":null,"context":"COG"},{"name":"PBTC_Text31","type":"Alternate Question Text","description":"Were samples provided for Circulating tumor DNA analysis?","url":null,"context":"PBTC"},{"name":"CRF Text12","type":"Alternate Question Text","description":"Were tissue specimens required to be submitted this reporting period?","url":null,"context":"Alliance"},{"name":"CRF Text9","type":"Alternate Question Text","description":"Were specimens submitted?","url":null,"context":"Alliance"},{"name":"CRF Text10","type":"Alternate Question Text","description":"Were biobanking specimens submitted?","url":null,"context":"Alliance"},{"name":"CRF Text11","type":"Alternate Question Text","description":"Were blood specimens required to be submitted this reporting period?","url":null,"context":"Alliance"},{"name":"PBTC_Text32","type":"Alternate Question Text","description":"Was FFPE tumor tissue provided for c-MET IHC Study?","url":null,"context":"PBTC"},{"name":"PBTC_Text34","type":"Alternate Question Text","description":"Were FFPE tumor tissue (or frozen tissue) and blood provided for genomic analysis of c-MET signaling axis and related cancer genes?","url":null,"context":"PBTC"},{"name":"PBTC_Text33","type":"Alternate Question Text","description":"Was FFPE tumor tissue provided for c-MET FISH analysis?","url":null,"context":"PBTC"},{"name":"PBTC_Text30","type":"Alternate Question Text","description":"Was a PK CSF sample without Ommaya collected?","url":null,"context":"PBTC"},{"name":"CRF Text13","type":"Alternate Question Text","description":"Were specimens required to be submitted this reporting period?","url":null,"context":"Alliance"},{"name":"COG_CRF_TEXT_22","type":"Alternate Question Text","description":"Were bone marrow specimens collected for Pharmacodynamics study","url":null,"context":"COG"},{"name":"CRF Text14","type":"Alternate Question Text","description":"Were bone marrow or blood specimens submitted during this reporting period for the sub-study?","url":null,"context":"Alliance"},{"name":"CRF Text15","type":"Alternate Question Text","description":"Were bone marrow or blood specimens submitted during this reporting period for Biobanking?","url":null,"context":"Alliance"},{"name":"CRF Text16","type":"Alternate Question Text","description":"Were blood and/or bone marrow specimens submitted during this reporting period for Biobanking?","url":null,"context":"Alliance"},{"name":"CRF Text18","type":"Alternate Question Text","description":"Were blood or tissue specimens required to be submitted this reporting period for biobanking?","url":null,"context":"Alliance"},{"name":"CRF Text17","type":"Alternate Question Text","description":"Were blood or tissue specimens submitted this reporting period for biobanking?","url":null,"context":"Alliance"},{"name":"CRF Text25","type":"Alternate Question Text","description":"Were urine specimens submitted this reporting period?","url":null,"context":"Alliance"},{"name":"CRF Text26","type":"Alternate Question Text","description":"Are skin swab samples for sub study A221803-ST1 required at current visit?","url":null,"context":"Alliance"},{"name":"PBTC_Text35","type":"Alternate Question Text","description":"Were samples collected for Western Blot, EM, Elisa and ctDNA?","url":null,"context":"PBTC"},{"name":"CRF Text23","type":"Alternate Question Text","description":"Were specimens required to be submitted during this reporting period for Biobanking?","url":null,"context":"Alliance"},{"name":"CRF Text24","type":"Alternate Question Text","description":"Were blood specimens required to be submitted during this reporting period for Biobanking?","url":null,"context":"Alliance"},{"name":"CRF Text20","type":"Alternate Question Text","description":"Were blood specimens required to be submitted this reporting period for biobanking?","url":null,"context":"Alliance"},{"name":"CRF Text19","type":"Alternate Question Text","description":"Were specimens required to be submitted this reporting period for biobanking?","url":null,"context":"Alliance"},{"name":"CRF Text27","type":"Alternate Question Text","description":"Were laboratory specimens collected this reporting period?","url":null,"context":"Alliance"},{"name":"CRF Text28","type":"Alternate Question Text","description":"Were urine specimens collected this reporting period?","url":null,"context":"Alliance"},{"name":"COG CRF TEXT 27","type":"Alternate Question Text","description":"Were specimens collected for MRD Flow Cytometry with CD123 Site Density Quantification studies?","url":null,"context":"COG"},{"name":"COG CRF Text 01","type":"Alternate Question Text","description":"Were the indicated specimens obtained for NGS MRD Comparison with Flow Cytometry MRD analysis?","url":null,"context":"COG"},{"name":"COG CRF Text 02","type":"Alternate Question Text","description":"Were the indicated specimens obtained for profiling of the tumor microenvironment?","url":null,"context":"COG"},{"name":"COG_CRF_TEXT_001","type":"Alternate Question Text","description":"Were specimens collected for the baseline CD123 Site Density Quantification studies?","url":null,"context":"COG"},{"name":"COG CRF TEXT 15","type":"Alternate Question Text","description":"Were specimens collected for the baseline CD123 Site Density Quantification studies?","url":null,"context":"COG"},{"name":"PBTC_Text37","type":"Alternate Question Text","description":"Blood samples collected for pharmacodynamics study (serum Her2)?","url":null,"context":"PBTC"},{"name":"PBTC_Text38","type":"Alternate Question Text","description":"CSF samples collected for pharmacodynamics study (NLGN3)?","url":null,"context":"PBTC"},{"name":"CRF Text22","type":"Alternate Question Text","description":"Were stool specimens required to be submitted this reporting period?","url":null,"context":"Alliance"},{"name":"CRF Text21","type":"Alternate Question Text","description":"Are correlative specimens for A171601-PP1 required at this visit?","url":null,"context":"Alliance"},{"name":"COG_CRF_TEXT 28","type":"Alternate Question Text","description":"Were specimens obtained for correlative biology study","url":null,"context":"COG"},{"name":"CRF Text30","type":"Alternate Question Text","description":"were tissue specimens submitted this reporting period?","url":null,"context":"Alliance"},{"name":"PBTC_Text36","type":"Alternate Question Text","description":"Were samples collected for PK studies?","url":null,"context":"PBTC"},{"name":"COG CRF Text 39","type":"Alternate Question Text","description":"Were Gilteritinib PK samples collected?","url":null,"context":"COG"},{"name":"CRF Text29","type":"Alternate Question Text","description":"Were blood specimens collected this reporting period?","url":null,"context":"Alliance"},{"name":"COG CRF Text 29","type":"Alternate Question Text","description":"Was ctDNA collected?","url":null,"context":"COG"},{"name":"PBTC_Text40","type":"Alternate Question Text","description":"Were samples provided for the CSF study?","url":null,"context":"PBTC"},{"name":"COG CRF Text 40","type":"Alternate Question Text","description":"Were the indicated specimens obtained to identify biomarkers of response?","url":null,"context":"COG"},{"name":"PBTC_Text39","type":"Alternate Question Text","description":"Were samples provided for the Whole Exomes study?","url":null,"context":"PBTC"},{"name":"PBTC_Text42","type":"Alternate Question Text","description":"Were samples provided for the Survivin Expression for DIPG?","url":null,"context":"PBTC"},{"name":"PBTC_Text41","type":"Alternate Question Text","description":"Were FFPE Tumor Tissue samples provided for the PD-L1 Expression?","url":null,"context":"PBTC"},{"name":"PBTC_Text43","type":"Alternate Question Text","description":"Were blood samples provided for Immune Response Monitoring?","url":null,"context":"PBTC"},{"name":"COG CRF TEXT 30","type":"Alternate Question Text","description":"Were IMGN632 PK samples collected?","url":null,"context":"COG"},{"name":"PBTC_Text44","type":"Alternate Question Text","description":"Were samples provided for Survivin Expression analysis?","url":null,"context":"PBTC"},{"name":"PBTC text 45","type":"Alternate Question Text","description":"Was tissue collected for Next-Gen Sequencing?","url":null,"context":"PBTC"},{"name":"COG CRF Text 22","type":"Alternate Question Text","description":"Does the patient have a pre-treatment biopsy or archival tumor tissue from within 12 months prior to ComboMATCH registration?","url":null,"context":"COG"},{"name":"PBTC text 47","type":"Alternate Question Text","description":"Was blood collected for plasma cfDNA","url":null,"context":"PBTC"}],"origin":"COG CRF:Children's Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F792B1BA-C066-43A6-E053-731AD00A8364","latestVersionIndicator":"Yes","beginDate":"2013-01-31","endDate":null,"createdBy":"ZHWENDY","dateCreated":"2023-03-23","modifiedBy":"KUMMEROA","dateModified":"2023-06-05","changeDescription":"Replaced VD Assessments Ind-3b 2958018v1 with VD ID#3506036 - Yes No Not Applicable Indicator - dbw Version 2 Short name changed - FAS Changed from CTEP to COG for by script Thu Jan 2 10:00:57 EST 2014","administrativeNotes":"2023.6.5 Released. ak 2023.3.29 AQT added per ticket request CADSR0002221. ak 3/23/2023: created new version due to new version DEC and added AQTs per cDSR0002181.wz","unresolvedIssues":null,"deletedIndicator":"No"}}